Comparative study evaluates gamma passing rates in VMAT plans, suggesting MobiusFX as a reliable verification tool.
MobiusFX showed interchangeable gamma passing rates with measurement-based methods at the 3%/3 mm and 3%/2 mm criteria, supporting its use as an alternative for VMAT pretreatment verification. Machine- and system-specific factors should be considered for reliable clinical implementation.
No takes yet. Share an insight, caveat, or question.
Sawapabmongkon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: